Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

NCT00175955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyskinesia, Medication-induced

Interventions

DRUG: Levetiracetam

Sponsor

UCB Pharma